The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key territories has introduced significant risk . Investors are now assessing the consequences o